The investigation centers on whether the board of directors and Priore fulfilled their fiduciary duties during negotiations for the Delaware-incorporated company. While the merger agreement, announced on September 21, 2026, received approval from a special committee of the board, legal experts at BFA Law are questioning if the process provided adequate safeguards for public investors.
Shareholders currently holding PRTH stock are being encouraged to review their legal standing regarding the transaction. BFA Law, a firm recognized for its work in securities class actions and high-profile settlements—including recoveries from Tesla and Teva Pharmaceutical—is operating on a contingency basis for this inquiry. The firm aims to determine if the cash-out price reflects the company’s true value or if the controller-led buyout undervalues minority stakes.

Comments (0)
No comments yet. Be the first!